PubMed:23326249 JSONTXT

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":141,"end":149},"obj":"HP_0000726"},{"id":"T2","span":{"begin":184,"end":193},"obj":"HP_0001300"},{"id":"T3","span":{"begin":201,"end":211},"obj":"HP_0000716"}],"text":"The risk of developing depression when suffering from neurological diseases.\nAIM OF THE STUDY: To investigate the comorbidity of Alzheimer's/dementia, epilepsy, multiple sclerosis and Parkinson's with depression.\nMETHODS: 42,914 patients who were newly diagnosed with the four comorbid diseases were included in the study. We analyzed how many of these patients developed depression within five years.\nRESULTS: Between 21% (males with epilepsy) and 39% (women with Parkinson's)/44% (Alzheimer's patients under 60 years) developed depression within five years.\nCONCLUSION: We recommend routine checks for depression in patients diagnosed with one of these diseases, especially in the most comorbid ones."}